1. Home
  2. core 10 scoring

Updating the Canadian Hemophilia Outcomes–Kids' Life Assessment Tool (CHO‐KLAT) in the era of extended half‐life clotting factor concentrates - Research and Practice in Thrombosis and Haemostasis

$ 20.50

4.6 (439) In stock

Acquired Haemophilia A: A Review of What We Know

Guidelines For The Management of Hemophilia: 2 Edition

PDF) Development and preliminary testing of a Paediatric Version of the Haemophilia Activities List (pedhal)

Hemophilia treatment options

Extended half-life factor IX prophylaxis up to every 21 days in hemophilia B: a longitudinal analysis of the efficacy and safety in selected adult patients - Research and Practice in Thrombosis and

Saunya Dover's research works SickKids, Toronto and other places

Acquired hemophilia A (AHA): underreported, underdiagnosed, undertreated medical condition, The Egyptian Journal of Internal Medicine

Hemophilia Steps for Living

Hemophilia market is boiling- new players, new products and drug wars.

PDF) Cross-cultural adaptation of the CHO-KLAT for boys with hemophilia in rural and urban China

Advances in Hemophilia A Management - Advances in Pediatrics

Understanding Hemophilia Treatment and Costs

Oral Communication abstracts - 2022 - Research and Practice in